Pages that link to "Q36916050"
Jump to navigation
Jump to search
The following pages link to Comprehensive microRNA Profiling of Prostate Cancer (Q36916050):
Displaying 50 items.
- Role of microRNAs in the resistance of prostate cancer to docetaxel and paclitaxel (Q26769599) (← links)
- Downregulation of microRNA-23a suppresses prostate cancer metastasis by targeting the PAK6-LIMK1 signaling pathway (Q28257722) (← links)
- A novel miRNA-based predictive model for biochemical failure following post-prostatectomy salvage radiation therapy (Q28543958) (← links)
- Micrornas in prostate cancer: an overview (Q30234658) (← links)
- miRNAs associated with prostate cancer risk and progression (Q30235186) (← links)
- Different miRNA expression profiles between human breast cancer tumors and serum (Q33663601) (← links)
- Heterogeneity of miRNA expression in localized prostate cancer with clinicopathological correlations (Q33811802) (← links)
- Down-regulation of miR-29b in carcinoma associated fibroblasts promotes cell growth and metastasis of breast cancer (Q33889273) (← links)
- Systematic identification and characterization of RNA editing in prostate tumors (Q33921151) (← links)
- MicroRNA profiling of ovarian granulosa cell tumours reveals novel diagnostic and prognostic markers (Q33922687) (← links)
- Binding sites of miR-1273 family on the mRNA of target genes (Q34162122) (← links)
- Noncoding RNAs as novel biomarkers in prostate cancer (Q34176890) (← links)
- Role of microRNAs and DNA Methyltransferases in Transmitting Induced Genomic Instability between Cell Generations (Q34180561) (← links)
- A potential regulatory loop between Lin28B:miR‑212 in androgen-independent prostate cancer. (Q34432845) (← links)
- The association between abnormal microRNA-10b expression and cancer risk: a meta-analysis (Q34708173) (← links)
- miR-193a-3p functions as a tumor suppressor in lung cancer by down-regulating ERBB4. (Q34958888) (← links)
- Decreased expression of microRNA-126 is associated with poor prognosis in patients with cervical cancer (Q34987355) (← links)
- microRNA-184 functions as tumor suppressor in renal cell carcinoma (Q35048683) (← links)
- Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs (Q35092050) (← links)
- Mir-184 post-transcriptionally regulates SOX7 expression and promotes cell proliferation in human hepatocellular carcinoma (Q35099688) (← links)
- MicroRNA Regulating Glutathione S-Transferase P1 in Prostate Cancer (Q35163033) (← links)
- Expression profile analysis of microRNAs in prostate cancer by next-generation sequencing (Q35544302) (← links)
- Noncoding RNAs that associate with YB-1 alter proliferation in prostate cancer cells (Q35621452) (← links)
- Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer. (Q35791145) (← links)
- MicroRNA-212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence (Q35800562) (← links)
- Integrated Analysis Reveals together miR-182, miR-200c and miR-221 Can Help in the Diagnosis of Prostate Cancer (Q35814277) (← links)
- MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1. (Q35955257) (← links)
- Loss of miR-449a in ERG-associated prostate cancer promotes the invasive phenotype by inducing SIRT1. (Q35961920) (← links)
- TR4 nuclear receptor increases prostate cancer invasion via decreasing the miR-373-3p expression to alter TGFβR2/p-Smad3 signals (Q36021034) (← links)
- miR-9 Acts as an OncomiR in Prostate Cancer through Multiple Pathways That Drive Tumour Progression and Metastasis. (Q36083567) (← links)
- miR-215 functions as a tumor suppressor and directly targets ZEB2 in human non-small cell lung cancer (Q36085367) (← links)
- miR-198 Represses the Proliferation of HaCaT Cells by Targeting Cyclin D2. (Q36088417) (← links)
- microRNAs and DICER1 are regulated by 1,25-dihydroxyvitamin D in prostate stroma. (Q36250216) (← links)
- MicroRNA-29B (mir-29b) regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3 (Q36562171) (← links)
- Serum expression levels of microRNA-382-3p, -598-3p, -1246 and -184 in breast cancer patients (Q37000986) (← links)
- MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2. (Q37046835) (← links)
- MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery (Q37113174) (← links)
- Lower expressed miR-198 and its potential targets in hepatocellular carcinoma: a clinicopathological and in silico study (Q37211122) (← links)
- MicroRNA-184 Promotes Proliferation and Inhibits Apoptosis in HaCaT Cells: An In Vitro Study. (Q37237946) (← links)
- Age-associated miRNA alterations in skeletal muscle from rhesus monkeys reversed by caloric restriction (Q37256245) (← links)
- Identification of aberrant microRNA expression pattern in pediatric gliomas by microarray (Q37369463) (← links)
- Comprehensive microRNA profiling of prostate cancer cells after ionizing radiation treatment. (Q37588824) (← links)
- Enhanced shedding of extracellular vesicles from amoeboid prostate cancer cells: potential effects on the tumor microenvironment (Q37692454) (← links)
- MiR-198 represses tumor growth and metastasis in colorectal cancer by targeting fucosyl transferase 8. (Q37743883) (← links)
- Microenvironmental regulation of cancer metastasis by miRNAs. (Q38152548) (← links)
- Cancer development, progression, and therapy: an epigenetic overview. (Q38154977) (← links)
- Role of microRNA in response to ionizing radiations: evidences and potential impact on clinical practice for radiotherapy. (Q38216239) (← links)
- Role of miRNA in head and neck squamous cell carcinoma (Q38264776) (← links)
- Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration. (Q38434637) (← links)
- Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development? (Q38667456) (← links)